Published in Gene Therapy Weekly, November 2nd, 2006
Study 1: According to recent research from the United States, adenoviral p53 gene therapy is promising for cancer.
"Mutations in the p53 gene are the most frequent genetic alterations in human tumours, occurring in approximately 50% of all cancers. The p53 protein is pivotal in maintaining genetic integrity after DNA damage, and alterations in the p53 pathway, including mutations in the p53 gene, greatly increase the probability of tumor formation," wrote D.I. Gabrilovich and colleagues, University of Southern Florida.
"Gene therapy using adenoviral p53 has emerged...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.